Phase 2 Breast Cancer Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 20 to 70 years old.
- People with a confirmed diagnosis of invasive breast cancer for whom a sentinel lymph node biopsy has been determined to be an appropriate procedure.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a history of allergic reactions to iodine, ICG (a medical dye), blue dye, Voluven (a fluid used in medical procedures), or Mannitol (a medication used in medical settings).
- People with a history of an overactive thyroid gland, thyroid cancer, or similar thyroid conditions.
- People who are currently pregnant, breastfeeding, or have a breast infection.
- People with impaired mental capacity or who belong to vulnerable populations (confirm with trial site for specific definitions).
- People who have already received chemotherapy treatment before surgery (known as neoadjuvant chemotherapy).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Number of sentinel lymph nodes; Fluorescence signal-to-background ratio of the lymph nodes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.